Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy

• Anne Hansen Ree ,

  * E-mail: a.h.ree@medisin.uio.no

  Affiliations Department of Oncology, Akershus University Hospital, Lørenskog, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Marie Grøn Saelen,

  Affiliations Department of Tumor Biology, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  ⨯
• Erta Kalanxhi,

  Affiliation Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Ingrid H. G. Østensen,

  Affiliation Department of Genes and Environment, Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Kristina Schee,

  Affiliation Department of Tumor Biology, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway

  ⨯
• Kathrine Røe,

  Affiliation Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Torveig Weum Abrahamsen,

  Affiliation Department of Tumor Biology, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway

  ⨯
• Svein Dueland,

  Affiliation Department of Oncology, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway

  ⨯
• Kjersti Flatmark

  Affiliations Department of Tumor Biology, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway, Department of Gastroenterological Surgery, Oslo University Hospital – Norwegian Radium Hospital, Oslo, Norway

  ⨯